Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.080 | 6 | 154062523 | intron variant | T/C | snv | 0.17 |
|
Chemically-Induced Disorders; Mental Disorders | 0.020 | 1.000 | 2 | 2015 | 2017 | |||||||
|
1.000 | 0.040 | 6 | 154086832 | 5 prime UTR variant | C/T | snv | 9.8E-02 |
|
Pathological Conditions, Signs and Symptoms | 0.020 | 1.000 | 2 | 2009 | 2017 | |||||||
|
0.882 | 0.080 | 6 | 154010889 | 5 prime UTR variant | A/G | snv | 2.1E-05 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.080 | 6 | 154010889 | 5 prime UTR variant | A/G | snv | 2.1E-05 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.080 | 6 | 154010889 | 5 prime UTR variant | A/G | snv | 2.1E-05 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
6 | 154100709 | intron variant | G/T | snv | 0.49 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
1.000 | 0.040 | 6 | 154185294 | intron variant | A/G | snv | 0.63 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.040 | 6 | 154090869 | intron variant | G/C | snv | 0.54 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.040 | 6 | 154090869 | intron variant | G/C | snv | 0.54 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.120 | 6 | 154157305 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.120 | 6 | 154157305 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.080 | 6 | 154062523 | intron variant | T/C | snv | 0.17 |
|
0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
6 | 154097279 | intron variant | G/A | snv | 0.15 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
1.000 | 0.080 | 6 | 154058017 | intron variant | G/A | snv | 0.14 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.120 | 6 | 154150090 | intron variant | G/A | snv | 0.54 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 6 | 154150090 | intron variant | G/A | snv | 0.54 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
6 | 154047863 | intron variant | G/A | snv | 5.5E-02 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
1.000 | 0.080 | 6 | 154040884 | intron variant | C/T | snv | 0.25 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
1.000 | 0.080 | 6 | 154040884 | intron variant | C/T | snv | 0.25 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.080 | 6 | 154047032 | intron variant | T/C | snv | 0.19 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.080 | 6 | 154043167 | intron variant | G/A | snv | 0.19 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.040 | 6 | 154086832 | 5 prime UTR variant | C/T | snv | 9.8E-02 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
6 | 154097624 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
6 | 154103824 | intron variant | T/A;C | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||||
|
6 | 154121116 | 3 prime UTR variant | G/A;C;T | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2014 | 2014 |